Congress trades
Novo Nordisk A/S (NVO)
About Novo Nordisk A/S
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Maziar Mike Doustdar
- Employees
- 68,794
- Listed since
- Apr 30, 1981
- Market value
- $197.9B
- Price to earnings
- 11.0
- Earnings per share
- $26.30
- Dividend yield
- 4.06%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $0.96 | $0.82 | $12.1B | $10.9B | EPS beatRevenue beat |
| Q1 FY2026reported May 6, 2026 | $1.04 | $0.87 | $11.0B | $10.9B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 3, 2026 | $1.00 | $0.90 | $12.5B | $12.1B | EPS beatRevenue beat |
| Q3 FY2025reported Nov 5, 2025 | $1.02 | $0.77 | $11.5B | $11.9B | EPS beatRevenue miss |
| Q2 FY2025reported Aug 6, 2025 | $0.97 | $0.93 | $12.0B | $11.9B | EPS beatRevenue in line |
| Q1 FY2025reported May 7, 2025 | $0.92 | $0.92 | $11.9B | $11.7B | EPS in lineRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Dodge & Cox | $977.8M | 20,397,110 | +5.5% | 0.46% |
| Loomis Sayles & Co L P | $891.4M | 18,594,352 | +9.3% | 0.42% |
| Franklin Resources Inc | $625.2M | 13,041,109 | -18.9% | 0.29% |
| Susquehanna International Group, LLP | $575.7M | 12,009,200 | +161.1% | 0.27% |
| Price T Rowe Associates Inc | $561.1M | 11,704,719 | +5.8% | 0.26% |
| Morgan Stanley | $559.0M | 11,659,869 | +7.3% | 0.26% |
| Bank Of America Corp | $535.8M | 11,176,712 | +3.8% | 0.25% |
| Capital International Investors | $467.6M | 9,721,180 | -17.6% | 0.22% |
| Folketrygdfondet | $456.5M | 9,522,383 | +4.9% | 0.21% |
| Goldman Sachs Group Inc | $440.1M | 9,180,490 | +79.3% | 0.21% |
| Citadel Advisors LLC | $434.3M | 9,059,400 | -5.3% | 0.20% |
| Citadel Advisors LLC | $423.4M | 8,831,400 | +12.7% | 0.20% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in NVO
20 disclosures of 53 on record · median 22d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $15,001 - $50,000 | +26.3%S&P +20.7% · vs S&P 500 +5.6% | Mar 30, 2026 | Jul 21, 2026 | 113d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +17.4%S&P +15.1% · vs S&P 500 +2.3% | Mar 13, 2026 | Apr 7, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -10.1%S&P +11.8% · vs S&P 500 -21.9% | Feb 13, 2026 | Mar 9, 2026 | 24d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | -10.5%S&P +12.3% · vs S&P 500 -22.8% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | -10.5%S&P +12.3% · vs S&P 500 -22.8% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | -9.5%S&P +12.0% · vs S&P 500 -21.4% | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | -17.5%S&P +16.1% · vs S&P 500 -33.6% | Sep 11, 2025 | Oct 22, 2025 | 41d |
| Marjorie Taylor Greene | Stock | Purchase | $1,001 - $15,000 | -21.4%S&P +14.6% · vs S&P 500 -36.1% | Oct 15, 2025 | Oct 20, 2025 | 5d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | -8.3%S&P +21.0% · vs S&P 500 -29.3% | Aug 4, 2025 | Sep 12, 2025 | 39d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | -60.2%S&P +31.1% · vs S&P 500 -91.3% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Marjorie Taylor Greene | Stock | Purchase | $1,001 - $15,000 | -20.6%S&P +17.5% · vs S&P 500 -38.1% | Aug 28, 2025 | Aug 29, 2025 | 1d |
| Marjorie Taylor Greene | Stock | Purchase | $15,001 - $50,000 | -18.7%S&P +19.2% · vs S&P 500 -37.8% | Aug 19, 2025 | Aug 20, 2025 | 1d |
| Scott Franklin | Stock | Purchase | $15,001 - $50,000 | -8.7%S&P +20.8% · vs S&P 500 -29.5% | Aug 4, 2025 | Aug 14, 2025 | 10d |
| Scott Franklin | Stock | Purchase | $1,001 - $15,000 | -8.7%S&P +20.8% · vs S&P 500 -29.5% | Aug 4, 2025 | Aug 14, 2025 | 10d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | -40.7%S&P +27.3% · vs S&P 500 -68.0% | Jun 9, 2025 | Aug 13, 2025 | 65d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | -36.9%S&P +22.0% · vs S&P 500 -59.0% | Jul 10, 2025 | Aug 13, 2025 | 34d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -10.5%S&P +20.4% · vs S&P 500 -30.9% | Jul 30, 2025 | Aug 13, 2025 | 14d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -34.6%S&P +23.8% · vs S&P 500 -58.5% | Jun 27, 2025 | Jul 7, 2025 | 10d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -41.9%S&P +26.7% · vs S&P 500 -68.6% | Jun 16, 2025 | Jul 7, 2025 | 21d |
| Laurel M. LeeSpouse | Stock | Sale | $1,001 - $15,000 | -31.3%S&P +35.0% · vs S&P 500 -66.2% | May 8, 2025 | Jun 22, 2025 | 45d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
5 members · estimate, as of Sep 10, 20265 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Scott Franklin | Republican · House | $50,001 - $100,000 | 2.1% |
| J. French Hill | Republican · House | $50,001 - $100,000 | 0.4% |
| Marjorie Taylor Greene | Republican · House | $15,001 - $50,000 | 0.9% |
| Kevin Hern | Republican · House | $15,001 - $50,000 | 0.1% |
| Mark Harris | Republican · House | $1,001 - $15,000 | 0.7% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded NVO?
Alan Armstrong, Ro Khanna, Lisa C. McClain, Marjorie Taylor Greene, Val T. Hoyle, Scott Franklin and others disclosed NVO transactions in the filings shown here.
Which members of Congress hold NVO?
5 members of Congress report a position in NVO in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Scott Franklin, J. French Hill and Marjorie Taylor Greene. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are NVO trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.